| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-05 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0002 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0008 |
| mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
| mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0009 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0009 |
| mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
| mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |